Literature DB >> 24450766

Trends in the prevalence of gestational diabetes mellitus in southern Sweden, 2003-2012.

Claes Ignell1, Rickard Claesson, Eva Anderberg, Kerstin Berntorp.   

Abstract

There is accumulating evidence that gestational diabetes is a growing problem. The lack of internationally standardized diagnostic procedures prevents consistent diagnosis and the burden of gestational diabetes must be determined in country-specific studies. In southern Sweden, gestational diabetes is defined as a 2-h capillary plasma glucose concentration of ≥10.0 mmol/L during a universal 75-g oral glucose tolerance test. We report the crude prevalence of gestational diabetes during the years 2003-2012. Of 156 144 women who gave birth, 2.2% were diagnosed with gestational diabetes. When the effect of time on the prevalence of gestational diabetes was assessed in a log-linear Poisson model, an overall increase in prevalence of 35% was predicted, corresponding to an average annual increase of 3.4%. Predicted prevalence was 1.9 (95% CI 1.8-2.0) in 2003 and 2.6 (95% CI 2.4-2.7) in 2012 (p < 0.0001). Due to a simultaneous rise in birth rate, the number of women diagnosed with gestational diabetes increased by 64%.
© 2014 Nordic Federation of Societies of Obstetrics and Gynecology.

Entities:  

Keywords:  Gestational diabetes mellitus; epidemiology; oral glucose tolerance test; pregnancy; prevalence; screening; trend

Mesh:

Substances:

Year:  2014        PMID: 24450766     DOI: 10.1111/aogs.12340

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  25 in total

1.  Randomized Face-to-Face vs. Home Exercise Interventions in Pregnant Women with Gestational Diabetes.

Authors:  Danielle Symons Downs; Jennifer M Dinallo; Leann L Birch; Ian M Paul; Jan S Ulbrecht
Journal:  Psychol Sport Exerc       Date:  2017-02-20

2.  Randomized controlled trial of induction at 38 weeks versus 40 weeks gestation on maternal and infant outcomes in women with insulin-controlled gestational diabetes.

Authors:  Katharina Worda; Dagmar Bancher-Todesca; Peter Husslein; Christof Worda; Heinz Leipold
Journal:  Wien Klin Wochenschr       Date:  2017-09       Impact factor: 1.704

Review 3.  Charting the Maternal and Infant Microbiome: What Is the Role of Diabetes and Obesity in Pregnancy?

Authors:  Sirtaj Singh; Margaret R Karagas; Noel T Mueller
Journal:  Curr Diab Rep       Date:  2017-02       Impact factor: 4.810

Review 4.  Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective.

Authors:  Yeyi Zhu; Cuilin Zhang
Journal:  Curr Diab Rep       Date:  2016-01       Impact factor: 4.810

5.  No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study.

Authors:  Maria Lindqvist; Margareta Persson; Marie Lindkvist; Ingrid Mogren
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-31       Impact factor: 3.007

6.  The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes.

Authors:  Jonatan Dereke; Sanna Palmqvist; Charlotta Nilsson; Mona Landin-Olsson; Magnus Hillman
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

7.  Is maternal weight gain between pregnancies associated with risk of large-for-gestational age birth? Analysis of a UK population-based cohort.

Authors:  Nida Ziauddeen; Sam Wilding; Paul J Roderick; Nicholas S Macklon; Nisreen A Alwan
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

8.  Low maternal vitamin B12 status is associated with lower cord blood HDL cholesterol in white Caucasians living in the UK.

Authors:  Antonysunil Adaikalakoteswari; Manu Vatish; Alexander Lawson; Catherine Wood; Kavitha Sivakumar; Philip G McTernan; Craig Webster; Neil Anderson; Chittaranjan S Yajnik; Gyanendra Tripathi; Ponnusamy Saravanan
Journal:  Nutrients       Date:  2015-04-02       Impact factor: 5.717

9.  Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 Diabetes.

Authors:  Pernilla Katra; Jonatan Dereke; Charlotta Nilsson; Magnus Hillman
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

10.  Model for individual prediction of diabetes up to 5 years after gestational diabetes mellitus.

Authors:  Claes Ignell; Magnus Ekelund; Eva Anderberg; Kerstin Berntorp
Journal:  Springerplus       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.